While clinical trials will always encounter challenges in driving quality experiences and data, there exists one approach that’s backed by regulatory agencies and proven to deliver better outcomes. This is a “quality by design” strategy that’s informed and driven by all stakeholders, including those most affected by your trial’s protocols – your participants, and sites. Learn why a participant-first, quality-by-design approach is key for improving clinical data quality.